Navigation Links
Fuisz Pharma LLC Develops a New Generation of Oral Solid Dosage Form Shapes That Facilitate Swallowing and Esophageal Transit
Date:4/6/2011

MIAMI, April 6, 2011 /PRNewswire/ -- Fuisz Pharma LLC announced today a new generation of solid dosage form designs that facilitate swallowing and esophageal transit.

Clinical studies demonstrate that these new designs and principles thereof speed esophageal transit by 80%, ease the swallowing experience, and reduce the incidence of esophageal transit failure, as compared with the conventional tablet designs currently used.

Joseph Fuisz, managing partner of Fuisz Pharma stated: "We stand at a crossroads where there is a keen understanding of the importance of compliance and the challenges to compliance posed by an aging population throughout the developed world.  At the same time however, cost containment pressures -- manifested primarily in reimbursement schemes -- make it challenging for branded pharma to broadly adopt value added drug delivery technologies."

"Our intention with this effort was to take existing tablet granulations and approach the question of form – as it relates to swallowability – from first principles.  The results were quite astonishing in that we demonstrated the ability to make enormous improvements in the swallowability of conventionally manufactured dosage forms.  Literally, we are able to take the existing granulation and stamp out a dramatically better performing product.  This advance also applies to capsules.  We are pursuing new dosage form classification for these next generation shapes in order to properly recognize their therapeutic value and to maximize the life cycle management benefit to our partners."

Richard C. Fuisz, M.D., a founder of Fuisz Pharma, commented: "I have had the privilege of making substantial contributions to the development and commercialization of orally dissolving tablets and orally soluble films, both of which were granted new dosage form classification to distinguish them from the then existing dosage forms.  Our new solid dosage for
'/>"/>

SOURCE Fuisz Pharma LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Fuisz Pharma Releases Clinical Photos of Its Opioid Abuse Detection System
2. Fuisz Announces Issuance of Patent for the New Generation of Glucose and Other Analyte Analyzers
3. Fuisz Pharma Announces Acquisition of Key Anti Opiate Abuse Patent to Complement its Anti Opiate Abuse Platform
4. FUISZ Announces Advances in Devices and Solid Dosage Form
5. Fuisz Pharma Announces Novel Anti Abuse System for Opiates
6. Fuisz Tobacco Announces Clinical Study Results for Fuisz Tobacco Sheet Strip; Super Enhanced Bioavailability of Nicotine From Its Tobacco Sheet Strip Supports Efficacy of Low Dose Tobacco Product
7. Harnessing Patients Good Intentions Can Cut 33% of Americas Pharmacy-Related Waste
8. Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
9. Valeant Pharmaceuticals Files Preliminary Consent Solicitation Statement With the SEC
10. ACLJ Gets Win for Pro-Life Pharmacy Owners in Illinois After Lengthy Legal Battle
11. Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Raises Target Price to $3.22
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... and CAMBRIDGE, Mass., May 17, 2013   ... a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) securities ... for the District of Massachusetts . ... officers violated the Securities Exchange Act of 1934 (the ... 2013 (the "Class Period"). (Logo: http://photos.prnewswire.com/prnh/20130103/MM36754LOGO ...
(Date:5/17/2013)... Ill. , May 17, 2013  Sony Biotechnology ... Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting ... which will be held at the San ... Diego, California , from May 20 - 22.  ... second analytical system, incorporating commercial audio-visual technologies into new ...
(Date:5/17/2013)... , May 17, 2013 ... economics and outcomes research also   to   be ... SHPG ), the global specialty biopharmaceutical company, ... poster presentations at the American Psychiatric Association (APA) 166th ... May 18-22. The data being presented represent Shire,s ongoing ...
Breaking Medicine Technology:Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10
(Date:5/19/2013)... In partnership with the medical practice online marketing company, JD ... SEO website for dentists. The purpose of the site is ... http://www.e-dentists.com/ , A perk to the service is that ... results. Dentists can request the keywords they want included in ... Surge, LLC rank high for competitive keywords. Dentists can rely ...
(Date:5/19/2013)... 19, 2013 According to a ... and Forecast (2013 – 2018): By Applications (Healthcare ... Technology (CCD, CMOS, Contact IS, Infrared, X-Ray) And ... sensor market was $8.00 billion in 2012 and ... at an estimated CAGR of 3.84% from 2013 ...
(Date:5/19/2013)... The Pradaxa lawyers at Bernstein Liebhard ... convened for hundreds of Pradaxa bleeding lawsuits ... U.S. District Court, Southern District of Illinois. According ... 14th, the Conference addressed the status of depositions and ... Conference that Defendants submitted a list of early trial ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Vegas Hotel ... is proud to announce the launch it's all new ... the MGM Grand on 5/19/2013. Consumers traveling to Las ... special pricing available on VegasHotelEscapes.com's website. Travelers will be ... beat any competitors price. , Vegas Hotel Escapes specializes ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
Breaking Medicine News(10 mins):Health News:Effective New Dental SEO Solution Launched by E-dentists.com in Partnership with JD Media Surge, LLC 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2
... polyphenol compounds affect areas involved with learning and memory , , ... the cognitive problems that come with obstructive sleep apnea (OSA), ... appear to negate the increased oxidative stress that affects brain ... with OSA, reports the study, published in the second issue ...
... than ten million Americans whove received drug-eluting stents to ... according to new research from the University of Pennsylvania ... large follow-up studies to show a clear, lifesaving benefit ... be published in the May 27 issue of the ...
... DALLAS, May 22 Parks Associates and ... host a free pre-show session,at CONNECTIONS(TM) on ... a,non-profit, open-industry coalition of the finest healthcare ... improve the quality of,personal healthcare by establishing ...
... Effects Significant for Adult Acne Sufferers, LOS ANGELES, ... a teenage "rite of passage," results from a groundbreaking,national ... that also,commonly affects adults. The survey finds that acne ... professional, academic, physical and,social -- and a basic lack ...
... Brewer Announces Fundraiser As Part Of Its Summer-Long Harley-Davidson ... 105th Anniversary Celebration Promotion, MILWAUKEE, ... the Muscular Dystrophy Association (MDA) for every Miller Lite,bottle cap ... brand,s,"Better. Bolder. Summer" promotion. Miller Lite, the "ultimate light beer,",is ...
... tumor-suppressor p53 could just as easily shelter a mutant version ... rather than die, according to research by scientists at The ... the current issue of the journal Genes and Development. ... p53, we need to make sure we first know what ...
Cached Medicine News:Health News:Green Tea May Help Brain Cope With Sleep Disorders 2Health News:More patients with drug-coated cardiac stents survive, avoid costly follow-up procedures 2Health News:Continua Health Alliance Provides Insight Into Next Generation of Digital Health at CONNECTIONS(TM) 2Health News:Acne - Not Just a Teen Issue 2Health News:Acne - Not Just a Teen Issue 3Health News:Acne - Not Just a Teen Issue 4Health News:Acne - Not Just a Teen Issue 5Health News:Acne - Not Just a Teen Issue 6Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 2Health News:Miller Lite Bottle Caps Equal Cash for MDA This Summer 3Health News:Stabilizing cancer-fighting p53 can also shield a metastasis-promoter 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: